GO:0004888 transmembrane signaling receptor activity: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0004888 transmembrane signaling receptor activity describes the molecular function of combining with an extracellular or intracellular signal and transmitting it across a membrane to initiate a change in cell activity or state.
This activity is carried out by structurally diverse receptor families, including seven-transmembrane receptors, cytokine receptors, and synthetic transmembrane receptors.
Receptor activation often involves conformational changes, oligomerization, and recruitment of intracellular effectors such as beta-arrestin or JAK kinases.
Dysregulated transmembrane signaling underlies many diseases, including inflammatory disorders, neuropsychiatric conditions, and cancer.
CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of receptor function in disease contexts.
EDITGENE provides end-to-end CRISPR services, including library screening and bioinformatics, to accelerate transmembrane receptor research.

Description

Transmembrane signaling receptor activity (GO:0004888) is a fundamental molecular function that enables cells to sense and respond to extracellular or intracellular signals by transmitting information across a membrane. This activity is essential for signal transduction, allowing a signal to initiate a change in cell activity or state. Receptors with this activity are central to physiology and are implicated in numerous diseases, making them key targets for research and therapeutic development. Understanding the mechanisms, genes, and regulatory networks of transmembrane signaling receptors is critical for advancing both basic biology and clinical applications.

transmembrane signaling receptor activity At A Glance

GO ID GO:0004888
GO term transmembrane signaling receptor activity
Ontology molecular_function
Synonym transmembrane receptor activity; transmembrane signalling receptor activity
Major function Binding an extracellular or intracellular signal and transmitting it across a membrane to initiate a change in cell activity or state
Related processes Signal transduction, cell communication, response to external stimuli
Example receptor families Seven-transmembrane receptors, cytokine receptors, synthetic receptors
Disease relevance Inflammation, neuropsychiatric disorders, cancer

What Is GO:0004888?

GO:0004888 transmembrane signaling receptor activity is defined as the molecular function of combining with an extracellular or intracellular signal and transmitting that signal from one side of the membrane to the other, thereby initiating a change in cell activity or state as part of signal transduction. This activity is synonymous with transmembrane receptor activity and transmembrane signalling receptor activity.

Why Is transmembrane signaling receptor activity Important in Cell Biology?

Transmembrane signaling receptor activity is essential for converting extracellular and intracellular cues into cellular responses, and its dysregulation is linked to a wide range of human diseases, including inflammatory and autoimmune conditions, neuropsychiatric disorders, and cancer. Studying this activity helps researchers understand fundamental signal transduction mechanisms and identify therapeutic targets.
Enables cells to respond to hormones, cytokines, neurotransmitters, and other signals.
Critical for immune cell activation and inflammatory responses.
Involved in neuropsychiatric effects of hallucinogens via agonist-trafficking.
Mediates platelet-activating factor signaling in inflammation and allergy.
Seven-transmembrane receptors regulate diverse physiological processes through beta-arrestin.
Synthetic transmembrane receptors can program artificial cells for biotechnology.
Dysregulation contributes to cancer, autoimmunity, and neurological disorders.
Targets for drug discovery, including receptor engineering and biased agonism.
CRISPR models enable causal validation of receptor function in disease.
Bioinformatics and library screening accelerate receptor gene discovery.

What Happens During transmembrane signaling receptor activity?

Signal Binding and Receptor Activation
In simple terms: A signal molecule binds to the receptor, causing the receptor to change shape and become active.
Transmembrane signaling receptor activity begins with the binding of an extracellular or intracellular signal to the receptor, which induces conformational changes that activate the receptor. This activation can involve dimerization or oligomerization, as seen in cytokine receptors and synthetic receptors. The activated receptor then transmits the signal across the membrane to initiate downstream signaling.
Signal Transmission Across the Membrane
In simple terms: The receptor passes the signal from outside to inside the cell.
Upon activation, the receptor undergoes structural rearrangements that propagate the signal from one side of the membrane to the other. For seven-transmembrane receptors, this involves coupling to heterotrimeric G proteins or beta-arrestin. Synthetic receptors can similarly transmit signals in artificial cells.
Initiation of Intracellular Signaling Cascades
In simple terms: The receptor triggers a chain of reactions inside the cell.
Activated receptors recruit and activate intracellular effectors, such as kinases or adaptor proteins, leading to phosphorylation cascades and changes in gene expression. For example, interferon receptors activate JAK-STAT pathways, while IL-23R signaling is controlled by intracellular motifs.
Feedback Regulation and Signal Termination
In simple terms: The cell has ways to turn off or adjust the signal.
Receptor signaling is tightly regulated by feedback mechanisms, including receptor internalization, desensitization, and degradation. Beta-arrestin plays a key role in desensitizing seven-transmembrane receptors, and receptor engineering can enhance robustness of IL-23R signaling.

Key Genes Involved in GO:0004888 transmembrane signaling receptor activity

The following genes encode receptors or signaling components that exhibit transmembrane signaling receptor activity or directly regulate it.
GeneMajor RoleResearch Relevance
IL23RCytokine receptor transmitting IL-23 signalsInflammatory diseases; receptor engineering
BAFFLigand for BAFF receptor, a transmembrane receptorB-cell survival and autoimmunity
ADRB2Seven-transmembrane beta-2 adrenergic receptorBeta-arrestin signaling; agonist trafficking
PTAFRPlatelet-activating factor receptorInflammation and allergy
IFNAR1Interferon-alpha/beta receptor subunitAntiviral and immune signaling
IFNAR2Interferon-alpha/beta receptor subunitInterferon signal transduction
JAK1Janus kinase associated with cytokine receptorsCytokine signaling
JAK2Janus kinase associated with cytokine receptorsCytokine signaling
STAT1Signal transducer and activator of transcriptionInterferon signaling
ARRB1Beta-arrestin 1Seven-transmembrane receptor desensitization
ARRB2Beta-arrestin 2Seven-transmembrane receptor signaling
HTR2ASerotonin 2A receptorHallucinogen effects; agonist trafficking
TNFRSF13CBAFF receptorB-cell survival
IL12RB1IL-12 receptor subunitCytokine signaling
IL12RB2IL-12 receptor subunitCytokine signaling
Synthetic receptorEngineered transmembrane receptorArtificial cell signaling

How Is transmembrane signaling receptor activity Regulated?

Transmembrane signaling receptor activity is regulated at multiple levels, including ligand availability, receptor expression, post-translational modifications, and feedback loops. Beta-arrestin mediates desensitization and internalization of seven-transmembrane receptors. Cytokine receptor signaling is modulated by intracellular motifs and feedback control, as shown for IL-23R. Interferon signaling is regulated by JAK-STAT feedback inhibitors.

transmembrane signaling receptor activity and Human Disease

GeneDisease / BiologyPotential Experimental Model
IL23RInflammatory bowel disease, psoriasisKnockout and point-mutation cell models
BAFFAutoimmunity, B-cell malignanciesKnock-in and overexpression models
HTR2ANeuropsychiatric disordersPoint-mutation and knockout models
PTAFRAllergy and inflammationKnockout and overexpression models
IFNAR1/2Viral infections, interferonopathiesKnockout and knock-in models
Transmembrane Signaling Receptors in Inflammation and Autoimmunity
Dysregulated cytokine receptor signaling, such as IL-23R, contributes to inflammatory and autoimmune diseases. BAFF and its receptor are critical for B-cell survival and are implicated in autoimmunity. Platelet-activating factor receptor mediates allergic and inflammatory responses.
Transmembrane Signaling Receptors in Neuropsychiatric Disorders
Serotonin 2A receptor (HTR2A) is a seven-transmembrane receptor whose agonist-trafficking properties influence hallucinogen effects, linking receptor signaling to neuropsychiatric conditions.
Transmembrane Signaling Receptors in Cancer
Altered transmembrane signaling receptor activity can promote tumor growth and survival. For example, cytokine receptors such as IL-23R and BAFF receptor are implicated in cancer-related inflammation and B-cell malignancies.

From transmembrane signaling receptor activity-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of receptor function affect signaling?CRISPR knockout cell line
Does a specific mutation alter receptor activity?CRISPR point-mutation knock-in
Does tagging the receptor affect localization?Tagged knock-in
Does overexpression drive oncogenic signaling?Overexpression cell model
Can synthetic receptors restore signaling?Synthetic receptor knock-in
What genes regulate receptor signaling?CRISPR library screening

How to Study the transmembrane signaling receptor activity Process

MethodWhat It MeasuresTypical Application
CRISPR knockoutLoss of receptor functionCausal gene validation
CRISPR point mutationSpecific amino acid changesStructure-function studies
Knock-in taggingReceptor localization and dynamicsLive-cell imaging
OverexpressionGain-of-function effectsOncogenic signaling
RNA-seqTranscriptional changesPathway analysis
ProteomicsProtein interactionsSignalosome composition
Flow cytometrySurface receptor levelsImmune cell phenotyping
CRISPR-Based Genetic Screens
CRISPR knockout and activation screens can identify genes that regulate transmembrane signaling receptor activity, as demonstrated for cytokine receptor signaling.
Biochemical Assays for Receptor Activation
Phosphorylation assays, immunoprecipitation, and Western blotting measure receptor activation and downstream signaling.
Imaging and Flow Cytometry
Fluorescence microscopy and flow cytometry assess receptor localization, internalization, and ligand binding.
Transcriptomics and Proteomics
RNA-seq and mass spectrometry reveal global changes in gene expression and protein interactions following receptor activation.

How CRISPR Can Be Used to Study GO:0004888 transmembrane signaling receptor activity

Knockout

CRISPR knockout of receptor genes abolishes transmembrane signaling receptor activity, enabling researchers to test necessity in disease models.

Point Mutation

Point mutations introduced by CRISPR can mimic disease-associated variants or disrupt specific signaling motifs, revealing structure-function relationships.

Knock-in

Knock-in of tagged or synthetic receptors allows tracking and engineering of transmembrane signaling receptor activity in cells and artificial systems.

Overexpression

Overexpression of receptors or their ligands can model gain-of-function states observed in cancer and autoimmunity.

How EDITGENE Supports transmembrane signaling receptor activity Research

Researchers studying transmembrane signaling receptor activity-related genes often need to determine whether a candidate gene is causally involved in a specific signaling pathway or disease phenotype. EDITGENE provides comprehensive CRISPR services to address these questions with precision and scale.
Contact EDITGENE today to design your custom CRISPR model for transmembrane signaling receptor activity research.

Frequently Asked Questions About transmembrane signaling receptor activity

It is the molecular function of binding a signal and transmitting it across a membrane to initiate a change in cell activity, defined as GO:0004888.
Genes include IL23R, BAFF, ADRB2, PTAFR, IFNAR1, IFNAR2, and others encoding receptors or signaling components.
Inflammatory diseases, autoimmunity, neuropsychiatric disorders, and cancer.
They activate heterotrimeric G proteins or beta-arrestin to transmit signals across the membrane.
Beta-arrestin desensitizes and internalizes seven-transmembrane receptors and can initiate independent signaling.
Yes, synthetic transmembrane receptors can transmit signals in artificial cells.
IL-23R signaling is controlled by intracellular motifs and feedback mechanisms.
It refers to different agonists inducing distinct signaling pathways at HTR2A, relevant to hallucinogens.
CRISPR knockout, point mutation, knock-in, and overexpression models enable causal studies of receptor function.
EDITGENE provides knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services.

Conclusion

Transmembrane signaling receptor activity (GO:0004888) is a cornerstone of cellular communication, with broad implications for health and disease. Understanding its mechanisms, genes, and regulation through CRISPR-based models and advanced methodologies will continue to drive therapeutic innovation.

References

  1. 1. Hollenberg MD. 1991. Structure-activity relationships for transmembrane signaling: the receptor's turn.. FASEB J 5(2):178-86 PMID: 1848518
  2. 2. Søgaard AB et al.. 2023. Transmembrane signaling by a synthetic receptor in artificial cells.. Nat Commun 14(1):1646 PMID: 36964156
  3. 3. Mackay F et al.. 2009. Cracking the BAFF code.. Nat Rev Immunol 9(7):491-502 PMID: 19521398
  4. 4. Shenoy SK et al.. 2005. Seven-transmembrane receptor signaling through beta-arrestin.. Sci STKE 2005(308):cm10 PMID: 16267056
  5. 5. Kashtanjeva L et al.. 2026. Receptor engineering constitutes feedback control and robustness of IL-23R signaling and highlights importance of intracellular cytokine receptor signaling motifs.. Cell Commun Signal 24(1):51 PMID: 41495840
  6. 6. González-Maeso J et al.. 2009. Agonist-trafficking and hallucinogens.. Curr Med Chem 16(8):1017-27 PMID: 19275609
  7. 7. Larner A et al.. 1996. Interferon signal transduction.. Biotherapy 8(3-4):175-81 PMID: 8813329
  8. 8. Ishii S et al.. 2002. Platelet-activating factor receptor.. Prostaglandins Other Lipid Mediat 68-69:599-609 PMID: 12432946
Contact Us
*
*
*
*
How did you hear about us: